Device Trial Radar · NCT00536744
Effectiveness of dermaPACE™ Device and Standard Treatment Compared to Standard Treatment Alone for Diabetic Foot Ulcers
Last checked: Nov 19, 2026Latest source record: Apr 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
206
Actual
Start
Oct 2007
Primary completion
Jun 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- SANUWAVE, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 28, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the safety and effectiveness of the dermaPACE Device to sham application, when administered in conjunction with standard treatments used in the treatment of DFUs.
Conditions
- Diabetic Foot Ulcers
Interventions
acoustical pulse energy (extracorporeal shockwave)Device
Acoustical pulse energy (extracorporeal shockwave) + Standard of care wound dressing.
ShamOther
Non-energized (inactive - Sham) application + standard of care
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Primary Variable for Effectiveness of the dermaPACE Device Will be Assessed by Comparing the Incidence of Complete Wound Closure of the dermaPACE and Control Groups 12 Weeks Post Initial Application.Time frame: 12 weeks post initial application
Locations
23 sites in 3 countries. Site status is shown where the registry gives one.
Phoenix VA Health Care System
Phoenix, Arizona
HOPE Research Insititute
Phoenix, Arizona
Southern Arizona VA Healthcare System (SAVAHCS)
Tucson, Arizona
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.